Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSatsuma Tech. Regulatory News (SATS)

Share Price Information for Satsuma Tech. (SATS)

Share Price is delayed by 15 minutes
Get Live Data
0.20    -0.0025 (-1.19%)
Bid:
0.195
Ask:
0.22
Spread: 0.025 (12.821%)
Market Cap: £22.41m
SATS Live PriceLast checked at - London Stock Exchange

Intraday Satsuma Tech. Share Chart

Publication of Prospectus

17 Dec 2025 12:37

RNS Number : 9812L
Satsuma Technology PLC
17 December 2025
 

This announcement is an advertisement for the purposes of the Prospectus Regulation Rules of the Financial Conduct Authority and not a prospectus. This announcement does not constitute or form part of, and should not be construed as, an offer for sale or subscription of, or solicitation of any offer to subscribe for or to acquire, any ordinary shares of Satsuma Technologies plc in any jurisdiction, including in or into or from the United States of America, Australia, Canada, Japan, the Republic of South Africa or in any other jurisdiction.

This announcement contains information which, prior to its disclosure, was inside information as stipulated under Regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310 (as amended). Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

 

17 December 2025

Satsuma Technology PLC

('Satsuma' or the 'Company')

Publication of Prospectus, issue of Ordinary Shares and proposed Admission

 

Satsuma Technology PLC (LSE: SATS) is pleased to announce that a prospectus (the "Prospectus") in relation to the proposed admission of its ordinary shares of £0.001 each ("Ordinary Shares") to the Equity Shares (Commercial Companies) Category of the Official List of the Financial Conduct Authority (the "FCA") and to trading on the Main Market of the London Stock Exchange (together, "Admission") has been approved by the FCA and published by the Company today.

Strategic transition

As detailed in the Company's strategy within the Prospectus, the Company intends to develop Bitcoin-based revenue lines, including Bitcoin staking and decentralised AI operations, to generate accretive cash flow that supports the continued accumulation of Bitcoin in the Company's treasury. This operational strategy will be implemented organically and through acquisitions. It is designed to complement the Company's treasury policy of holding Bitcoin as its primary reserve asset.

Issue of new Ordinary Shares and Financial Position

Following the approval of the Prospectus, £90,761,000 in nominal value of convertible loan notes (CLN 1 and CLN 2) will automatically convert in accordance with their terms. Consequently, on 18 December 2025, the Company will allot and issue 10,676,100,000 new Ordinary Shares ("New Shares"). The total issued share capital immediately following Admission will be 11,203,900,200 Ordinary Shares.

As announced on 11 December 2025, the Company holds approximately £90.0 million in cash. The Company intends to utilise this cash balance to repay approximately £78.2 million to remaining noteholders upon the maturity of the outstanding loan notes on 30 December 2025.

Following this repayment, the Company expects to retain approximately £11.8 million in cash and hold 620 Bitcoin (worth £40.5 million based on the current market price of Bitcoin) with no material liabilities. The asset base of the Company will therefore be approximately £52.3 million.

Admission

Admission is expected to take place at 8.00 a.m. on 19 December 2025 but may occur on any business day up to and including 31 December 2025.

Under Listing Rule 3.2.7R, the Company is required to have an expected market capitalisation of at least £30.0 million prior to Admission. As set out above, following the scheduled repayment of loan notes, the Company's asset base, comprising 620 Bitcoin worth £40.5 million and approximately £11.8 million cash, will be approximately £52.3 million. Consequently, the Board expects the Company's market capitalisation on Admission to significantly exceed the regulatory minimum.

Satsuma is not offering any new Ordinary Shares nor any other securities in connection with the proposed Admission. Following Admission, the Ordinary Shares will continue to be registered with their existing ISIN of GB00BMFCRZ80 and the TIDM will remain SATS.

The Prospectus has been approved by the FCA and will shortly be available to view on Satsuma's website, https://www.satsuma.digital/investors. A copy of the Prospectus will be submitted to the National Storage Mechanism and will be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

Total Voting Rights

For the purposes of the DTRs, the total number of Ordinary Shares in issue following the allotment and issue of the New Shares will be 11,203,900,200 with each Ordinary Share carrying the right to one vote. There are no Ordinary Shares held in treasury and therefore the total number of voting rights in the Company following the allotment and issue of the New Shares will be 11,203,900,200. The above figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the DTRs.

Capitalised terms used in the Prospectus have the same meanings in this announcement.

 

Henry K. Elder, CEO, commented:

"The publication of the Prospectus represents a definitive milestone in Satsuma's evolution. As a result, we will enter the new year with a strategy underpinned by a liquid debt-free balance sheet, securities listed on the UK Main Market, and a high-calibre leadership team.

"With these foundations in place, our singular focus shifts to execution and driving long-term shareholder value."

 

 

Satsuma Technology PLC

Henry K. Elder, CEO

Data Counsel

Steffan Williams

William Barker

+44 (0)20 3855 8888

satsuma@datacounsel.uk

+44 (0)7767 345 563

+44 (0)7534 068 657

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PDIUBUURVWUUAAA
Date   Source Headline
24th Jun 202611:08 amRNSProposed Return of Capital and Delisting
2nd Jun 20267:00 amRNSMonthly Update
6th May 202612:54 pmRNSUpdate
5th May 20267:00 amRNSMonthly Update
27th Apr 20267:00 amRNSAppointment of Auditor
24th Apr 20267:00 amRNSBitcoin Acquisition
7th Apr 20267:00 amRNSAppointment of Non-Executive Directors
2nd Apr 20267:00 amRNSCost Reduction Programme and Bitcoin Purchase
16th Mar 20267:00 amRNSUpdate on Board and intention to adjourn GM
16th Mar 20267:00 amRNSUpdate on Board and intention to adjourn GM
6th Mar 202610:07 amRNSResignation of Director
19th Feb 20261:43 pmRNSPublication of Circular and Notice of GM
18th Feb 202612:14 pmRNSResignation of Director
2nd Feb 20269:30 amRNSRequisition Notice
28th Jan 20264:10 pmRNSPurported Requisition Notice
23rd Jan 202610:36 amRNSHolding(s) in Company
19th Jan 20261:22 pmRNSHolding(s) in Company
6th Jan 20266:05 pmRNSTR-1: Standard notification of major holdings
19th Dec 20258:09 amRNSAdmission to Trading
19th Dec 20258:09 amRNSAdmission to Trading
19th Dec 20257:00 amRNSDirector/PDMR Shareholding
19th Dec 20257:00 amRNSDirector/PDMR Shareholding
17th Dec 202512:37 pmRNSPublication of Prospectus
17th Dec 202512:37 pmRNSPublication of Prospectus
11th Dec 20257:00 amRNSProposed Board changes and sale of Bitcoin
28th Nov 20251:42 pmRNSUnaudited Interim Results
28th Nov 20251:40 pmRNSUpdate non-statutory financial information
23rd Oct 20251:45 pmRNSAppointment of Auditor
16th Oct 20257:00 amRNSAppointment of Advisors
14th Oct 20257:00 amRNSAppointment of Chief Financial Officer
29th Sep 202512:22 pmRNSTR-1 NOTIFICATION
25th Sep 20257:00 amRNSUpdate on Prospectus and discussions with the FCA
12th Sep 20257:00 amRNSAuditor Transition in Line with Strategic Review
8th Sep 20255:45 pmRNSTR-1 Notification
2nd Sep 20255:48 pmRNSResults of General Meeting
1st Sep 20257:00 amRNSInterim Results to 8 August 2025
15th Aug 20251:12 pmRNSNotice of GM
15th Aug 20257:00 amRNSBoard Appointment
7th Aug 20257:00 amRNSExercise of Warrants
6th Aug 20258:05 amRNSSecond CLN Raises Gross Proceeds of £163.6m
4th Aug 20257:00 amRNSBoard Change
1st Aug 20257:00 amRNSBoard Appointment of Jonathan Jachym
24th Jul 20257:00 amRNSClosing of the second convertible loan note
15th Jul 20257:00 amRNSExercise of Warrants, PDMR and Grant of Warrants
14th Jul 20252:58 pmRNSChange of Name
14th Jul 20257:00 amRNSCEO Appointment and Bitcoin Purchase
10th Jul 20254:06 pmRNSInterim results for the three-month period
9th Jul 202512:57 pmRNSExercise of Warrants
9th Jul 20257:00 amRNSAppointment of Bitcoin Treasury Strategist
7th Jul 20257:00 amRNSProposed Board Appointment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.